CME
CME GROUP INC.Price
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Jan 9 ▲ Gilbert Cisneros bought $1,001 - $15,000, last disclosed Feb 16
- Mar 27 Paul Kuscher v. CME Group, Inc.
- Jun 16 ▼ Gilbert Cisneros sold $1,001 - $15,000, last disclosed Jul 3
- Jun 30 ▲ 7 funds open new positions (13F)
- Jul 20 ▲ Ro Khanna bought $1,001 - $15,000, last disclosed Aug 12
- Sep 25 ▲ 1 insider buy $78.6K at $268.76
- Oct 2 Wells Fargo initiates
- Oct 21 ▲ CME Group reported Q3 2026 revenue of $1.74B and adjusted diluted EP…
- Oct 21 ▲ Earnings: CME Q3 2026 Earnings: EPS $3.02 (+0.0% vs est)
- Oct 21 ▲ CME Group reported Q3 2026 adjusted EPS of $3.02, a 1.3% beat vs. $2…
- Oct 22 to Nov 9 ▼ 4 days of insider sells: $5.5M by 5 insiders, avg $303.03
- Oct 22 ▲ JP Morgan upgrades
Signal stack
Where each data set points today.
- InsidersBEARISH
1 insider bought $78.6K at an average $268.76. 5 insiders sold $5.5M. Price is 19% above their cost.
- InstitutionsBULLISH
Q2 2026: 76 added (7 new), 41 trimmed or exited. Largest new: Baupost Group /Ma $136.7M.
- AnalystsBULLISH
13 of 22 rate it Buy or better. Median target $328.50 (+3%).
- Short sellersSTEADY
Short interest +7.3% to 5.35M shares. 2.4 days to cover, ≈1.5% of shares.
- TrendUPTREND
11% above its 50-day average.
- SocialQUIET
Crowd 53° (neutral) this week from 12 mentions: 1 bullish, 0 bearish. No setup is alerting. Excludes 1 subscriber-only day.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| JPMORGAN CHASE & CO | TRIM | $1.3B |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | ADD | $718.9M |
| Capital Wealth Planning, LLC | ADD | $711.7M |
| BANK OF AMERICA CORP /DE/ | TRIM | $622.7M |
| MARSHALL WACE, LLP | DOUBLED | $494.9M |
| PRICE T ROWE ASSOCIATES INC /MD/ | TRIM | $461.3M |
| JANE STREET GROUP, LLC | DOUBLED | $400.9M |
| Qube Research & Technologies Ltd | DOUBLED | $355.8M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
22 analystsPrice is inside the target range. Median implies +3%.Targets as of Nov 16, 2026.
| Date | Firm | Rating |
|---|---|---|
| Oct 22, 2026 | UBS MAINTAIN | Neutral |
| Oct 22, 2026 | Morgan Stanley MAINTAIN | Overweight |
| Oct 22, 2026 | Barclays MAINTAIN | Equal-Weight |
| Oct 22, 2026 | Wells Fargo MAINTAIN | Overweight |
| Oct 22, 2026 | Piper Sandler REITERATE | Overweight |
| Oct 22, 2026 | JP Morgan UPGRADE | Overweight |
Washington
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Kaye Daniel G Director Nov 9, 2026 | SELL | $161.8K |
SIEGEL HOWARD J Director Nov 2, 2026 | SELL | $606.0K |
Winkler Julie Sr MD Chief Commercial Officer Nov 2, 2026 | SELL | $3.1M |
Cutinho Sunil Chief Information Officer Oct 27, 2026 | SELL | $1.5M |
GEPSMAN MARTIN J Director Oct 22, 2026 | SELL | $121.0K |
SHEPARD WILLIAM R Director Sep 25, 2026 | BUY | $78.6K |
Tobin Jack J MD Chief Accounting Officer Sep 16, 2026 | TAX W/H | $13.9K |
Sprague Suzanne COO & Global Head of Clearing Sep 16, 2026 | TAX W/H | $83.9K |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 30, 2026SecBot reports
29 filings · 7 bullish · 2 bearish · 2 mixed · 18 neutral- NEUTRAL CLUSTERNov 10, 2026
Three CME insiders sold a total of $3.84M in open-market sales over a 7-day window, including the…
The dollar amount is immaterial relative to CME's size. No follow-up catalyst is indicated by these routine sales. Monitor next 10-Q for any fundamental changes.
- NEUTRAL 144Nov 9, 2026
Director Daniel G. Kaye filed a Form 144 notice of intent to sell 532 shares of CME Group common…
The filing is a routine advance notice of a very small sale by a director. No material impact on the stock is expected. Monitor for any subsequent Form 4 filings to confirm execution.
- NEUTRAL CLUSTERNov 3, 2026
Three CME insiders (a director, the CIO, and a senior commercial officer) sold a total of $5.18M…
The dollar amount is trivial relative to CME's size, making this cluster routine. Monitor for any acceleration in insider selling volume or C-suite participation in future filings.
- NEUTRAL CLUSTERNov 2, 2026
Two CME insiders, the CIO and Chief Commercial Officer, sold a combined $4.57M in open-market…
The sales are too small relative to market cap to carry a directional signal. Monitor next 10-Q for any change in insider selling patterns or operating trends.
All CME filing & press-release reports (29)
- CLUSTER reportNov 10, 2026
- 144 reportNov 9, 2026
- CLUSTER reportNov 3, 2026
- CLUSTER reportNov 2, 2026
- 3 reportNov 2, 2026
- 144 reportNov 2, 2026
- 144 reportNov 2, 2026
- CLUSTER reportOct 27, 2026
- 144 reportOct 27, 2026
- INST-CLUSTER reportOct 23, 2026
- 144 reportOct 22, 2026
- JP Morgan upgrades CME to Overweight from Underweight, PT $367 (+24%)Oct 22, 2026
- 8-K reportOct 21, 2026
- PRESS-RELEASE reportOct 21, 2026
- Wells Fargo initiates CME at Overweight, PT $301 (+13.5%)Oct 2, 2026
- CLUSTER reportSep 14, 2026
- CLUSTER reportSep 14, 2026
- Deutsche Bank downgrades CME to Hold, PT $270 (-5.9%)Aug 19, 2026
- 8-K reportJul 22, 2026
- Keefe, Bruyette & Woods upgrades CME to Outperform, PT $305 (flat vs prior, +20.8% upside)Jun 18, 2026
- 8-K reportJun 17, 2026
- Rothschild & Co upgrades CME to Buy, PT $323 (+22.4%)Jun 11, 2026
- DEFA14A reportMay 19, 2026
- CLUSTER reportMay 19, 2026
- COURT-RULING reportMar 27, 2026
- 8-K reportApr 22, 2026
- DEFA14A reportMar 23, 2026
- CLUSTER reportMar 12, 2026
- CLUSTER reportMar 12, 2026